Ptc Therapeutics, Inc. · NASDAQ:PTCT

Almstead Neil Gregory sold 26,283 Ptc Therapeutics, Inc. shares (Form 4)

Traded Jun 24 to Jun 25, 2026 · Filed Jun 26, 2026

From Jun 24 to Jun 25, 2026, Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) sold 26,283 Ptc Therapeutics, Inc. shares at an average US$85.78 for US$2.25M under a trading plan, leaving 60,137 shares. Filed Jun 26, 2026 (Form 4).

Sold
26,283 shares
Price
US$85.78 average (US$85.01 to US$87.00)
Value
US$2.25M
Holding after
60,137 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CHIEF TECHNICAL OPS OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 24, 2026Common StockOption exercise401US$38.1060,538Direct
Jun 24, 2026Common StockSale401US$85.0160,137Direct
Jun 24, 2026Common StockOption exercise4,922US$38.1065,059Direct
Jun 24, 2026Common StockSale4,922US$85.0360,137Direct
Jun 25, 2026Common StockOption exercise1,001US$38.1061,138Direct
Jun 25, 2026Common StockSale582US$85.2460,556Direct
Jun 25, 2026Common StockSale419US$86.3960,137Direct
Jun 25, 2026Common StockOption exercise19,859US$38.1079,996Direct
Jun 25, 2026Common StockSale8,522US$85.2671,474Direct
Jun 25, 2026Common StockSale11,337US$86.5160,137Direct
Jun 25, 2026Common StockOption exercise100US$39.4260,237Direct
Jun 25, 2026Common StockSale100US$87.0060,137Direct

Source

View original at SEC

Related